Lobbying disclosures · Lobbying report
IQV: third_quarter 2026 lobbying report
Policies related to life science industry and clinical trial reform.
Follow IQV- Became public
- Oct 19, 2026, 1:15 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 8:29 AM EST
Why this is connected
Exact legal-name match: IQVIA HOLDINGS INC. (https://www.sec.gov/Archives/edgar/data/1478242/).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/e11a9c9f-7277-4b9e-81c4-96bc4ad032de/","filing_uuid":"e11a9c9f-7277-4b9e-81c4-96bc4ad032de","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/e11a9c9f-7277-4b9e-81c4-96bc4ad032de/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Minor, Partner","dt_posted":"2026-10-19T13:15:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 8th Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":76855,"url":"https://lda.gov/api/v1/registrants/76855/","house_registrant_id":32113,"name":"DLA PIPER LLP (US)","description":"Law firm.","address_1":"500 8th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM MINOR","contact_telephone":"+1 202-799-4312","dt_updated":"2026-07-30T08:35:35.415773-04:00"},"client":{"id":45035,"url":"https://lda.gov/api/v1/clients/45035/","client_id":45035,"name":"IQVIA HOLDINGS, INC.","general_description":"Human data science company.","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Policies related to life science industry and clinical trial reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139175,"prefix":"mr","prefix_display":"MR.","first_name":"JAMIE","nickname":null,"middle_name":"ALEXEI","last_name":"GREGORIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101694,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"PINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149501,"prefix":null,"prefix_display":null,"first_name":"VINCENT","nickname":null,"middle_name":null,"last_name":"SARUBBI","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":152192,"prefix":null,"prefix_display":null,"first_name":"MAREN","nickname":null,"middle_name":null,"last_name":"MCBRIDE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in IQV
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 25, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 25, 2026 · Joint
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Sep 8, 2026 · disclosed Sep 25, 2026 · Dependent
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Sep 3, 2026 · disclosed Sep 25, 2026 · Dependent
- Apr 3, 2026$50K–$100K
Rep. Kevin Hern (R-OK-1)
$50K–$100K · Traded Mar 16, 2026 · disclosed Apr 3, 2026 · Joint
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 16, 2026$15K–$50K
Sen. Markwayne Mullin (R-OK)
$15K–$50K · Traded Dec 29, 2025 · disclosed Jan 16, 2026 · Joint
- Nov 15, 2025$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) IQVIA Holdings IQV
$1K–$15K · Traded Oct 2, 2025 · disclosed Nov 15, 2025 · Joint
- May 31, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.